BABISS LEE,CLARK MATTHEW,KEEFE ANTHONY D,MULVIHILL MARK J,NI HAIHONG,RENZETTI LOUIS,RUEBSAM FRANK,WANG CE,XIE ZHIFENG,ZHANG YING
申请号：
AP2016009496
公开号：
AP2016009496A0
申请日:
2015.04.03
申请国别(地区):
AP
年份:
2016
代理人:
摘要：
The present invention relates to compounds according to Formula 1 and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus, mediated at least in part by ATX.
